Skip to main content
. 2021 Mar 26;4(2):898–907. doi: 10.1021/acsptsci.1c00022

Figure 6.

Figure 6

Disulfiram and ebselen can target multiple SARS-CoV-2 nsps to block the viral polyprotein cleavage and RNA replication/transcription. These Zn2+-ejector drugs target PLpro of nsp3 and Mpro of nsp5 to inhibit viral polypeptide proteolysis. They also directly target nsp10, nsp13, and nsp14 as well as indirectly target nsp12 and nsp16 to inhibit viral RNA genome replication and translation of the structural and accessory viral proteins. They can act in concert with remdesivir to synergistically inhibit SARS-CoV-2 replication.